The prostate cancer landscape in Europe: Current challenges, future opportunities

被引:26
|
作者
Marhold, Maximilian [1 ]
Kramer, Gero [2 ]
Krainer, Michael [1 ]
Le Magnen, Clementine [3 ,4 ]
机构
[1] Med Univ Vienna, Dept Med 1, Div Oncol, Waehringer Guertel 18-20, A-1090 Vienna, Austria
[2] Med Univ Vienna, Dept Urol, Vienna, Austria
[3] Univ Basel, Univ Hosp Basel, Inst Med Genet & Pathol, Pathol, Basel, Switzerland
[4] Univ Hosp Basel, Dept Urol, Basel, Switzerland
关键词
Prostate cancer; Treatment; Europe; ANDROGEN-DEPRIVATION THERAPY; PHASE-III TRIAL; RADICAL PROSTATECTOMY; DOUBLE-BLIND; OPEN-LABEL; PLUS PREDNISONE; DOCETAXEL; SURVIVAL; ENZALUTAMIDE; RADIOTHERAPY;
D O I
10.1016/j.canlet.2021.11.033
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Prostate cancer (PCa) is the most common non-cutaneous cancer in men in Europe and is predicted to exhibit declining mortality in the European Union (EU) due to various recent improvements in treatment. The goal of this short review is to give insight into the European treatment landscape of PCa, while focusing on improvements in care.
引用
收藏
页码:304 / 310
页数:7
相关论文
共 50 条
  • [31] Proton Therapy for Prostate Cancer: Challenges and Opportunities
    Poon, Darren M. C.
    Wu, Stephen
    Ho, Leon
    Cheung, Kin Yin
    Yu, Ben
    CANCERS, 2022, 14 (04)
  • [32] Antioxidants for prostate cancer chemoprevention: Challenges and opportunities
    Thapa, Dinesh
    Ghosh, Rita
    BIOCHEMICAL PHARMACOLOGY, 2012, 83 (10) : 1319 - 1330
  • [33] Liquid biopsy in prostate cancer: current status and future challenges of clinical application
    Wang, Yaqiong
    Wang, Zili
    Gang, Xiaokun
    Wang, Guixia
    AGING MALE, 2021, 24 (01): : 58 - 71
  • [34] Liquid Biopsy in Prostate Cancer Management-Current Challenges and Future Perspectives
    Crocetto, Felice
    Russo, Gianluca
    Di Zazzo, Erika
    Pisapia, Pasquale
    Mirto, Benito Fabio
    Palmieri, Alessandro
    Pepe, Francesco
    Bellevicine, Claudio
    Russo, Alessandro
    La Civita, Evelina
    Terracciano, Daniela
    Malapelle, Umberto
    Troncone, Giancarlo
    Barone, Biagio
    CANCERS, 2022, 14 (13)
  • [35] Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer
    Wallace, T. J.
    Torre, T.
    Grob, M.
    Yu, J.
    Avital, I.
    Bruecher, Bldm
    Stojadinovic, A.
    Man, Y. G.
    JOURNAL OF CANCER, 2014, 5 (01): : 3 - 24
  • [36] The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges
    Zhang, Fan
    Zhou, Yunxin
    Ding, Junying
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
  • [37] The current landscape of microRNAs (miRNAs) in bacterial pneumonia: opportunities and challenges
    Fan Zhang
    Yunxin Zhou
    Junying Ding
    Cellular & Molecular Biology Letters, 2022, 27
  • [38] Biomarkers: Opportunities and Challenges for Drug Development in the Current Regulatory Landscape
    Gromova, Mariya
    Vaggelas, Annegret
    Dallmann, Gabriele
    Seimetz, Diane
    BIOMARKER INSIGHTS, 2020, 15
  • [39] Immunotherapy and Novel Combinations in Oncology: Current Landscape, Challenges, and Opportunities
    Morrissey, K. M.
    Yuraszeck, T. M.
    Li, C-C
    Zhang, Y.
    Kasichayanula, S.
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2016, 9 (02): : 89 - 104
  • [40] The Current Landscape of Genetic Testing in Cardiovascular Malformations: Opportunities and Challenges
    Landis, Benjamin J.
    Ware, Stephanie M.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2016, 3